NovaBay Pharmaceuticals (NBY) Stock: Why Shares Exploded 103% on Friday

TLDR NovaBay Pharmaceuticals stock surged 103% Friday, closing at $19.16 with 10 million shares traded. The company sold Avenova trademark to PRN Physician Recommended Nutriceuticals effective January 17, 2025. NovaBay board approved dissolution plan for shareholder vote to unlock remaining value. Pre-funded warrants allow conversion to common shares after January 1, 2026, pending approval. Next [...]

The post NovaBay Pharmaceuticals (NBY) Stock: Why Shares Exploded 103% on Friday appeared first on Blockonomi.